Ballew Advisors, Inc Pfizer Inc Transaction History

Ballew Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $111,178 - $126,755	-2,890 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $344 - $418	10 Added 0.35%	2,890 $123,000
Q2 2018 Jul 30, 2018	BUY	$32.98 - $35.16 $395 - $421	12 Added 0.42%	2,880 $104,000
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $91,517 - $106,173	2,868 New	2,868 $102,000

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ballew Advisors, Inc with notifications on news.